---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-118006"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-11-10T21:05:21+00:00"
generated_at: "2026-11-10T21:07:16.850481+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tempest stockholders approve Lincoln Park 20% issuance and PIPE warrant proposals at 2026 annual meeting

## Summary
- Stockholders approved issuance of 20% or more of outstanding common stock under the Lincoln Park Capital Fund purchase agreement: 9,639,712 for, 490,295 against.
- PIPE proposal approved: 3,105,591 Series C and 3,105,591 Series D warrant shares, plus 217,391 placement agent warrants for H.C. Wainwright (SPA dated Sept 11, 2026).
- John David Yee re-elected Class II director (9,910,731 for, 235,236 withheld) and William Drake Richey (9,840,725 for, 305,242 withheld), terms running to the 2029 annual meeting.
- Ernst & Young LLP ratified as independent registered public accounting firm for fiscal year ending December 31, 2026: 10,111,485 for, 15,607 against, 18,875 abstentions.

## SEC filing metadata
- accession: 0001213900-26-118006
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-11-10T21:05:21+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000121390026118006/0001213900-26-118006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000121390026118006/ea0311733-8k_tempest.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-118006
- JSON: https://secwatch.observer/filing/0001213900-26-118006.json
- Plain text: https://secwatch.observer/filing/0001213900-26-118006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.